Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zafar Sharif is active.

Publication


Featured researches published by Zafar Sharif.


Psychiatry Research-neuroimaging | 2000

Positive symptomatology and source-monitoring failure in schizophrenia - an analysis of symptom-specific effects

Gildas Brébion; Xavier F. Amador; Anthony S. David; Dolores Malaspina; Zafar Sharif; Jack M. Gorman

Recent research has suggested that certain positive symptoms in patients with schizophrenia are linked to self monitoring/reality-monitoring deficits. We wished to investigate the association between such deficits and three specific symptoms: hallucinations, delusions and thought disorganisation. Forty patients with schizophrenia and 40 normal controls were administered a source-monitoring task. Twenty-four items were produced, either verbally by the experimenter, or verbally by the subject, or presented as pictures. Then, subjects were read a recognition list including the produced target items mixed with distractors. They were required to recognise the target items and to remember their source of production. The pattern of memory deficits has previously been reported (Brébion, G., Smith, M., Gorman, J., Amador, X., 1997. Discrimination accuracy and decision biases in different types of reality monitoring in schizophrenia. Journal of Nervous and Mental Disease 185, 247-253). The current analyses focussed on the false recognition of distractors, and on the errors in the source attribution of the recognised target items. Results showed that higher hallucination scores were associated with an increased tendency towards false recognition of non-produced items. In addition, hallucinators were more prone than control subjects to misattribute to another source the items they had produced themselves. Furthermore, hallucinators and delusional patients were more prone than the other patients to report that spoken items had been presented as pictures. This latter finding suggests that both hallucinations and delusions are associated with confusion between imagined and perceived pictures. Our previous report stated that only one of the three investigated types of response bias was associated with global positive symptomatology. However, this finer-grained analysis revealed that the three of them were in fact associated with hallucinations and/or delusions. On the other hand, thought disorganisation appeared to be independent from these mechanisms.


Psychiatry Research-neuroimaging | 2002

Source monitoring impairments in schizophrenia: characterisation and associations with positive and negative symptomatology

Gildas Brébion; Jack M. Gorman; Xavier F. Amador; Dolores Malaspina; Zafar Sharif

This article describes a consistent pattern of the associations between source monitoring failure and clinical symptomatology in schizophrenia. The associations with positive symptoms in this sample have been reported previously, but not the associations with negative symptoms. Forty patients with schizophrenia were administered several memory tasks including free recall of lists of words, recognition and source memory. Various memory errors assumed to stem from source monitoring failure were derived. They include intrusions and recall of words from previous lists in free recall, false recognitions, and confusion with regard to the source of the stimuli. We studied the associations of these memory errors with positive symptoms and with a broad range of negative symptoms. All the memory errors were positively associated with at least one positive symptom. On the other hand, these errors were inversely associated with certain negative symptoms reflecting lack of emotion or lack of social interactions. Thus positive and negative symptomatology appear to have opposite links to the source monitoring errors observed in patients with schizophrenia. Cognitive mechanisms leading to different types of source monitoring errors and possibly to the formation of positive symptoms are discussed.


Journal of Psychiatric Research | 2000

Memory and schizophrenia: differential link of processing speed and selective attention with two levels of encoding

Gildas Brébion; Mark J. Smith; Jack M. Gorman; Dolores Malaspina; Zafar Sharif; Xavier F. Amador

The purpose of this study was to investigate how underlying cognitive deficits such as a defect in processing speed or in selective attention contributed to different types of memory impairment observed in schizophrenia (superficial vs deep encoding). 49 schizophrenic patients and 40 normal controls were administered a verbal memory task. Superficial encoding was assessed by the ability to recall items in their serial order. Deep encoding was assessed by the ability to organise words into semantic categories. Two measures of processing speed (Digit Symbol Substitution Test and Stroop colour time) and one measure of selective attention (Stroop test) were used. Regression analyses were carried out. In the patient group, processing speed contributed to both superficial and deep encoding, and to a global verbal memory score. Selective attention only contributed to the superficial encoding processes. Thus, slowing of processing speed in schizophrenia seems to be more crucial for memory performance, since it affects memory in a pervasive way.


Psychiatry Research-neuroimaging | 1999

Opposite links of positive and negative symptomatology with memory errors in schizophrenia

Gildas Brébion; Xavier F. Amador; Mark J. Smith; Dolores Malaspina; Zafar Sharif; Jack M. Gorman

We wished to confirm and extend a previous correlational study of our group, suggesting that positive symptoms in schizophrenia were linked to an increase in certain types of memory errors, and negative symptoms to a decrease in other types of errors. A post-hoc analysis was conducted in 33 schizophrenic patients and 40 normal control subjects on memory errors collected in a free recall task and two types of recognition tasks. The memory errors were intrusions and list errors in free recall, and decision bias towards false alarms in recognition, all assumed to reflect a source-monitoring failure. In a first analysis, the patient sample was split along the median for positive symptoms as rated by the Scale for the Assessment of Positive Symptoms (SAPS). In a second analysis, it was split along the median for negative symptoms as rated by the Scale for the Assessment of Negative Symptoms (SANS). Patients with high ratings of positive symptoms made more memory errors (intrusions, list errors, false alarms) than those with low ratings, supporting the hypothesis of a link between positive symptomatology and source-monitoring failure. On the other hand, patients with high ratings of negative symptoms made fewer of these errors than the other patients. Fewer errors were specifically associated with more affective flattening, alogia and anhedonia, whereas avolition was entirely unrelated to them.


Psychiatric Quarterly | 1998

Treatment Refractory Schizophrenia: How should We Proceed?

Zafar Sharif

A substantial portion of schizophrenic patients demonstrate suboptimal response to conventional antipsychotics. These agents are primarily effective in the treatment of psychotic symptoms; their efficacy in other domains of psychopathology such as negative symptoms, chronic aggressive behavior, and cognitive deficits, is limited or non-existent. In this group of refractory patients, the novel atypical antipsychotic clozapine has demonstrated robust efficacy, with response rates approaching 60% after twelve weeks of treatment. Efficacy of clozapine extends to symptom domains other than psychosis, including negative symptoms, mood stabilization, aggressive behavior and compulsive water drinking. Several novel agents, each of which shares some, but not all, of the preclinical and clinical characteristics that make clozapine so unique, have been introduced in the last 4 years. These agents demonstrate a broader spectrum of efficacy and an improved side effect profile in non-refractory patients. Initial data on their efficacy in refractory patients suggests that olanzapine does not achieve overall superior efficacy in this patient population compared to conventional agents although there is some evidence of relatively greater efficacy in negative symptoms and aggressivity. Several studies suggest that the efficacy of risperidone is superior to that of conventional agents in refractory patients. Preliminary conclusions are not possible for quetiapine because of a paucity of data in the literature. The literature supports a risperidone trial prior to a clozapine trial in a treatment algorithm for refractory patients because of its more favorable risk/benefit profile.


Archives of General Psychiatry | 1999

Left Temporal Lobe Dysfunction in Schizophrenia: Event-Related Potential and Behavioral Evidence From Phonetic and Tonal Dichotic Listening Tasks

Gerard E. Bruder; Jürgen Kayser; Craig E. Tenke; Xavier F. Amador; Michelle Friedman; Zafar Sharif; Jack M. Gorman


The Journal of Clinical Psychiatry | 2008

Overview of Patient Care Issues and Treatment in Bipolar Spectrum and Bipolar II Disorder

John M. Kane; Zafar Sharif


Journal of Abnormal Psychology | 1998

The time course of visuospatial processing deficits in schizophrenia: An event-related brain potential study.

Gerard E. Bruder; Jürgen Kayser; Craig E. Tenke; Esther Rabinowicz; Michelle Friedman; Xavier F. Amador; Zafar Sharif; Jack M. Gorman


Neuropsychiatry Neuropsychology and Behavioral Neurology | 2000

Depression, psychomotor retardation, negative symptoms, and memory in schizophrenia.

Gildas Brébion; Xavier F. Amador; Mark J. Smith; Dolores Malaspina; Zafar Sharif; Jack M. Gorman


American Journal of Psychiatry | 2001

Clinical and Cognitive Factors Associated With Verbal Memory Task Performance in Patients With Schizophrenia

Gildas Brébion; Jack M. Gorman; Dolores Malaspina; Zafar Sharif; Xavier F. Amador

Collaboration


Dive into the Zafar Sharif's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mark J. Smith

Creedmoor Psychiatric Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michelle Friedman

Massachusetts Mental Health Center

View shared research outputs
Top Co-Authors

Avatar

Ahmad Raza

Southern Illinois University School of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge